Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway

Autophagy

Volumn 11, Issue 12, 2015, Pages 2309-2322

  Wei, Fu Zheng ^a   Cao, Ziyang ^a   Wang, Xi ^a   Wang, Hui ^a   Cai, Mu Yan ^b   Li, Tingting ^a   Hattori, Naoko ^c   Wang, Donglai ^a   Du, Yipeng ^a   Song, Boyan ^a   Cao, Lin Lin ^a   Shen, Changchun ^a   Wang, Lina ^a   Wang, Haiying ^a   Yang, Yang ^a   Xie, Dan ^b   Wang, Fan ^a   Ushijima, Toshikazu ^c   Zhao, Ying ^a   Zhu, Wei Guo ^a,d,e  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d Tsinghua University   (China)

^e Shenzhen University   (China)

Author keywords

Autophagy; EZH2; Histone modification; MTA2; MTOR pathway

Indexed keywords

BINDING PROTEIN; HISTONE H3; MAMMALIAN TARGET OF RAPAMYCIN; METASTASIS ASSOCIATED 1 FAMILY MEMBER 2 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR EZH2; TUBERIN; UNCLASSIFIED DRUG; EZH2 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE; MTOR PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2; TARGET OF RAPAMYCIN KINASE;

ADULT; ARTICLE; AUTOPHAGY; CANCER TISSUE; CARCINOGENESIS; CHROMATIN; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEPTOR GENE; DOWN REGULATION; ENZYME ACTIVATION; EPIGENETIC REPRESSION; EPIGENETICS; FEMALE; FKBP11 GENE; GENE; GENE EXPRESSION; GENE SILENCING; GPI GENE; HCT116 CELL LINE; HEK293 CELL LINE; HELA CELL LINE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MCF 7 CELL LINE; MIDDLE AGED; PROMOTER REGION; RGS16 GENE; RHOA GUANINE NUCLEOTIDE BINDING GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS 2 GENE; U2OS CELL LINE; GENETIC EPIGENESIS; GENETICS; METABOLISM;

AUTOPHAGY; DOWN-REGULATION; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; EPIGENESIS, GENETIC; HISTONE DEACETYLASES; HISTONES; HUMANS; POLYCOMB REPRESSIVE COMPLEX 2; TOR SERINE-THREONINE KINASES;

EID: 84964284813     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2015.1117734     Document Type: Article

References (60)

1. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8: 931-7; PMID: 17712358; http://dx.doi.org/10.1038/nrm2245
2. Mizushima N. Autophagy in Protein and Organelle Turnover. Cold Spring Harb Symp Quant Biol 2011; 76: 397-402; PMID: 21813637; http://dx.doi.org/10.1101/sqb.2011.76.011023
3. Feng Y, Yao Z, Klionsky DJ. How to control selfdigestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol 2015; 25: 354-63; PMID: 25759175; http:// dx.doi.org/10.1016/j.tcb.2015.02.002
4. Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 2015; 125: 25-32; PMID: 25654547; http://dx.doi.org/10.1172/JCI73939
5. Noda T, Ohsumi Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem 1998; 273: 3963-6; PMID: 9461583; http://dx.doi.org/10.1074/jbc.273.7.3963
6. Baehrecke EH. Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 2005; 6: 505-10; PMID: 15928714; http://dx.doi.org/10.1038/nrm1666
7. Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012; 11: 709-30; PMID: 22935804; http://dx.doi.org/10.1038/nrd3802
8. Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C. p65/RelAmodulates BECN1 transcription and autophagy. Mol Cell Biol 2009; 29: 2594-608; PMID: 19289499; http://dx.doi.org/10.1128/MCB.01396-08
9. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, et al. KrasG12Dinduced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21: 105-20; PMID: 22264792; http://dx.doi.org/10.1016/j.ccr.2011.12.006
10. Polager S, Ofir M, Ginsberg D. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene 2008; 27: 4860-4; PMID: 18408756
11. Mammucari C,MilanG, Romanello V, Masiero E, Rudolf R,Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, et al. FoxO3 controls autophagy in skeletalmuscle in vivo. Cell Metab 2007; 6: 458-71; PMID: 18054315; http://dx. doi.org/10.1016/j.cmet.2007.11.001
12. Zhou J, Liao W, Yang J, Ma K, Li X, Wang Y, Wang D, Wang L, Zhang Y, Yin Y, et al. FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway. Autophagy 2012; 8: 1712-23; PMID: 22931788; http://dx.doi.org/10.4161/ auto.21830
13. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6: 472-83; PMID: 18054316; http://dx.doi.org/10.1016/j.cmet.2007.11.004
14. Fullgrabe J, Klionsky DJ, Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol 2014; 15: 65-74; PMID: 24326622; http://dx.doi.org/10.1038/nrm3716
15. Kourmouli N, Jeppesen P, Mahadevhaiah S, Burgoyne P, Wu R, Gilbert DM, Bongiorni S, Prantera G, Fanti L, Pimpinelli S, et al. Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J Cell Sci 2004; 117: 2491-501; PMID: 15128874; http://dx.doi. org/10.1242/jcs.01238
16. Artal-Martinez de Narvajas A, Gomez TS, Zhang JS, Mann AO, Taoda Y, Gorman JA, Herreros-Villanueva M, Gress TM, Ellenrieder V, Bujanda L, et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol 2013; 33: 3983-93; PMID: 23918802; http://dx.doi.org/10.1128/MCB.00813-13
17. Fullgrabe J, Lynch-Day MA, Heldring N, Li W, Struijk RB, MaQ, HermansonO, RosenfeldMG, KlionskyDJ, Joseph B. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature 2013; 500: 468-71; PMID: 23863932; http://dx.doi.org/10.1038/nature12313
18. Badeaux AI, Shi Y. Emerging roles for chromatin as a signal integration and storage platform. Nat Rev Mol Cell Biol 2013; 14: 211-24; PMID: AMBIGUOUS; http://dx.doi.org/10.1038/nrm3545
19. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011; 21: 381-95; PMID: 21321607; http://dx.doi.org/10.1038/cr.2011.22
20. Jenuwein T, Allis CD. Translating the Histone Code. Science 2001; 293: 1074-80; PMID: 11498575; http:// dx.doi.org/10.1126/science.1063127
21. Li B, CareyM,Workman JL. The role of chromatin during transcription. Cell 2007; 128: 707-19; PMID: 17320508; http://dx.doi.org/10.1016/j.cell.2007.01.015
22. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447: 407-12; PMID: 17522673; http://dx.doi.org/10.1038/nature05915
23. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007; 25: 15-30; PMID: 17218268; http://dx.doi.org/10.1016/j. molcel.2006.12.014
24. Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007; 26: 5433-8; PMID: 17694084; http://dx.doi.org/10.1038/sj.onc.1210611
25. Schuettengruber B, Cavalli G. Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development (Cambridge, England) 2009; 136: 3531-42; PMID: 19820181; http://dx.doi.org/10.1242/dev.033902
26. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343-9; PMID: 21248841; http://dx.doi.org/10.1038/nature09784
27. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-26; PMID: 16630819; http://dx.doi. org/10.1016/j.cell.2006.02.041
28. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441: 349-53; PMID: 16625203; http:// dx.doi.org/10.1038/nature04733
29. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (New York, NY) 2002; 298: 1039-43; http:// dx.doi.org/10.1126/science.1076997
30. Tong JK, Hassig CA, Schnitzler GR, Kingston RE, Schreiber SL. Chromatin deacetylation by an ATPdependent nucleosome remodelling complex. Nature 1998; 395: 917-21; PMID: 9804427; http://dx.doi. org/10.1038/27699
31. Xue Y, Wong J, Moreno GT, Young MK, Cote J,Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998; 2: 851-61; PMID: 9885572; http://dx.doi. org/10.1016/S1097-2765(00)80299-3
32. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998; 95: 279-89; PMID: 9790534; http://dx.doi.org/10.1016/S0092-8674(00)81758-4
33. Kaji K, Caballero IM, MacLeod R, Nichols J, Wilson VA, Hendrich B. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat Cell Biol 2006; 8: 285-92; PMID: 16462733; http:// dx.doi.org/10.1038/ncb1372
34. Larsen DH, Poinsignon C, Gudjonsson T, Dinant C, Payne MR, Hari FJ, Rendtlew Danielsen JM, Menard P, Sand JC, Stucki M, et al. The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage. J Cell Biol 2010; 190: 731-40; PMID: 20805324; http://dx.doi.org/10.1083/ jcb.200912135
35. Polo SE, Kaidi A, Baskcomb L, Galanty Y, Jackson SP. Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4. EMBO J 2010; 29: 3130-9; PMID: 20693977; http://dx.doi.org/10.1038/emboj.2010.188
36. Smeenk G, WiegantWW, VrolijkH, Solari AP, Pastink A, van Attikum H. The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damage. J Cell Biol 2010; 190: 741-9; PMID: 20805320; http://dx.doi. org/10.1083/jcb.201001048
37. Feng Q, Zhang Y. The NuRD complex: linking histone modification to nucleosome remodeling. Curr TopMicrobiol Immunol 2003; 274: 269-90; PMID: 12596911
38. Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A, Morin RD, Mungall AJ, Meissner B, Boyle M, et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 2011; 117: 2451-9; PMID: 21190999; http://dx.doi.org/10.1182/blood-2010-11-321208
39. Reynolds N, Salmon-Divon M, Dvinge H, Hynes-Allen A, Balasooriya G, Leaford D, Behrens A, Bertone P, Hendrich B. NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J 2012; 31: 593-605; PMID: 22139358; http://dx.doi. org/10.1038/emboj.2011.431
40. Jung HY, Jun S, Lee M, Kim HC, Wang X, Ji H, McCrea PD, Park JI. PAF and EZH2 induce Wnt/ b-catenin signaling hyperactivation. Mol Cell 2013; 52: 193-205; PMID: 24055345; http://dx.doi.org/10.1016/j.molcel.2013.08.028
41. Zhao Y, Li X, Cai MY, Ma K, Yang J, Zhou J, Fu W, Wei FZ, Wang L, Xie D, et al. XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cells. Cell Res 2013; 23: 491-507; PMID: 23277279; http://dx.doi.org/10.1038/cr.2013.2
42. Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, et al. Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma. Cancer Res 2010; 70: 453-62; PMID: 20068170; http://dx.doi. org/10.1158/0008-5472.CAN-09-2189
43. Du W, Wang S, Zhou Q, Li X, Chu J, Chang Z, Tao Q, Ng EK, Fang J, Sung JJ, et al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene 2013; 32: 3319-28; PMID: 22907434; http:// dx.doi.org/10.1038/onc.2012.359
44. Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, Wang D, Feng J, Yu L, Zhu WG. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 2010; 12: 665-75; PMID: 20543840; http://dx.doi.org/10.1038/ncb2069
45. Wilkinson FH, Park K, Atchison ML. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci U S A 2006; 103: 19296-301; PMID: 17158804; http://dx.doi.org/10.1073/ pnas.0603564103
46. Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 2010; 140: 99-110; PMID: 20085705; http://dx.doi.org/10.1016/j.cell.2009.12.022
47. Xi H, Yu Y, Fu Y, Foley J, Halees A, Weng Z. Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. Genome Res 2007; 17: 798-806; PMID: 17567998; http://dx.doi. org/10.1101/gr.5754707
48. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Gen Dev 2010; 24: 368-80; PMID: 20123894; http://dx.doi.org/10.1101/gad.1886410
49. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M, Tommerup N, Rappsilber J, Helin K. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010; 464: 306-10; PMID: 20075857; http://dx.doi. org/10.1038/nature08788
50. Margueron R, Justin N, Ohno K, Sharpe ML, Son J, Drury WJ, Voigt P, Martin SR, Taylor WR, De Marco V, et al. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 2009; 461: 762-7; PMID: 19767730; http://dx.doi. org/10.1038/nature08398
51. Lai AY, Wade PA. Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nat Rev Cancer 2011; 11: 588-96; PMID: 21734722; http://dx. doi.org/10.1038/nrc3091
52. Nicolson G, Nawa A, Toh Y, Taniguchi S, Nishimori K, Moustafa A. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: Role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 2003; 20: 19-24; PMID: 12650603; http://dx.doi.org/10.1023/ A: 1022534217769
53. Bagheri-Yarmand R, Talukder AH, Wang RA, Vadlamudi RK, Kumar R. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development (Cambridge, England) 2004; 131: 3469-79; PMID: 15226262; http:// dx.doi.org/10.1242/dev.01213
54. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003; 113: 207-19; PMID: 12705869; http://dx.doi.org/10.1016/S0092-8674(03)00234-4
55. Zhang H, Singh RR, Talukder AH, Kumar R. Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Gen Dev 2006; 20: 2943-8; PMID: 17050676; http://dx.doi.org/10.1101/gad.1461706
56. Manavathi B, Kumar R. Metastasis Tumor Antigens, an Emerging Family of Multifaceted Master Coregulators. J Biol Chem 2007; 282: 1529-33; PMID: 17142453; http://dx.doi.org/10.1074/jbc.R600029200
57. Wu LP, Wang X, Li L,Zhao Y, Lu S, Yu Y, ZhouW, Liu X, Yang J, Zheng Z, et al. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol 2008; 28: 3219-35; PMID: 18332107; http://dx. doi.org/10.1128/MCB.01516-07
58. Wang D, Zhou J, Liu X, Lu D, Shen C, Du Y, Wei F-Z, Song B, Lu X, Yu Y, et al. Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability. Proc Natl Acad Sci 2013; 110: 5516-21; http:// dx.doi.org/10.1073/pnas.1216596110
59. Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, Burlingame AL, Roeder RG, Brivanlou AH, Allis CD. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 2005; 121: 859-72; PMID: 15960974; http://dx.doi. org/10.1016/j.cell.2005.03.036
60. Xie D, Ma N-F, Pan Z-Z, Wu H-X, Liu Y-D, Wu GQ, Kung H-F, Guan X-Y. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol 2008; 39: 80-6; PMID: 17949776; http://dx.doi.org/10.1016/j.humpath.2007.05.011